Edition:
United Kingdom

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

5.73USD
8:59pm GMT
Change (% chg)

$-0.05 (-0.87%)
Prev Close
$5.78
Open
$5.77
Day's High
$5.86
Day's Low
$5.68
Volume
22,333
Avg. Vol
38,374
52-wk High
$10.80
52-wk Low
$5.68

Chart for

About

ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of its drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving... (more)

Overall

Beta: 1.56
Market Cap(Mil.): $404.27
Shares Outstanding(Mil.): 48.71
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Chemocentryx reports Q3 revenue $9.0 million

* Chemocentryx reports third quarter 2017 financial results and recent highlights

07 Nov 2017

BRIEF-ChemoCentryx qtrly basic and diluted net loss per share $0.19

* ChemoCentryx reports second quarter 2017 financial results and recent highlights

08 Aug 2017

Competitors

Earnings vs. Estimates